ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Contracting in a Click: DocJuris Secures Series A Funding

By: Prodigy
09/30/2024, Houston, Texas // PRODIGY: Feature Story //

DocJuris, a leader in AI contract review, announced today the successful closure of its Series A funding round, raising $8 million in new capital, bringing the total capital raised to date to $11.2 million. The round was led by Silverton Partners, the most active venture capital firm in Texas, with participation from previous investors Watertower Ventures, Surface Ventures, and Seed Round Capital.

DocJuris’s AI-powered contract negotiation software automates key tasks during the review, redlining, and negotiation of contracts. These capabilities come at a critical time for enterprise teams and general counsels. In a DocJuris survey of 700+ in-house attorneys and contract administrators, an astonishing 74% of companies manually review and draft contracts, amounting to significant errors and time lost in legal operations, sales cycles, and supply chain management.

The key to DocJuris’s success has been rooted in unmatched AI functionality that makes contract negotiations lightning-fast, compliant, and more enjoyable. Several Fortune 500 companies — including Siemens, Dell, FedEx, Toyota, and Duke Energy — leverage DocJuris for various contract management tasks. They use the platform to screen third-party contracts in seconds, redline clauses with playbook-compliant edits in one click, and generate perfectly formatted track changes, exception tables, and amendments — all from a streamlined, cloud-based application.

“DocJuris AI has become an industry-leading platform that empowers enterprise legal, procurement, and sales teams to close deals faster while reducing risk,” said Henal Patel, CEO and Founder of DocJuris. “With this funding, we will continue scaffolding our platform around generative AI, expand our customer success team, and grow our user base.”

The Association of Corporate Counsel, the largest network of enterprise in-house counsel in the world, awarded DocJuris the Value Champion Award in 2023 for reducing contract cycle times to minutes with AI. This prestigious award is given to only 1% of legal technology vendors and was part of a DocJuris customer case study with Flex, a Global Fortune 500 electronics manufacturing company.

Iringo Csifo-Nagy, Lead Attorney for Flex’s Global Procurement and Supply Chain, stated, “The average turnaround time for redlining a complex supply chain agreement was eight days, and our contract volumes were increasing. It was time for a change. We wanted to replace repetitive, manual tasks and free up valuable time for our employees to focus on more impactful work. To achieve this, we developed a turnkey solution for AI-driven contract reviews together with the DocJuris team.”

About DocJuris

Headquartered in Houston, DocJuris is a dynamic legal tech company committed to revolutionizing contract review and negotiation with its state-of-the-art AI platform. Led by a seasoned team of legal professionals and tech enthusiasts, DocJuris optimizes contract review processes, guarantees policy alignment, and reduces contract negotiation timeframes.

For press inquiries only:

PR Contact Name: Kirsten LeBouef

Email: press@docjuris.com

For more information on DocJuris:

https://www.docjuris.com/



Source: Prodigy.press

Release ID: 1133569

This content was first published by KISS PR Brand Story. Read here >> Contracting in a Click: DocJuris Secures Series A Funding


Recent Quotes

View More
Symbol Price Change (%)
AMZN  208.72
-1.60 (-0.76%)
AAPL  274.62
-3.50 (-1.26%)
AMD  216.00
+7.56 (3.63%)
BAC  56.41
-0.12 (-0.21%)
GOOG  324.40
+1.30 (0.40%)
META  677.22
+15.76 (2.38%)
MSFT  413.60
+12.46 (3.11%)
NVDA  190.04
+4.63 (2.50%)
ORCL  156.59
+13.77 (9.64%)
TSLA  417.32
+6.21 (1.51%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.